Sir: In a recent supplement of the Companion, the utilization of benzodiazepines in clinical practice was reviewed.1 In that supplement, several authors advised caution in prescribing benzodiazepines to patients with histories of alcohol (p. 5) or substance abuse (p. 23). We were curious about the actual percentage of patients for whom this precaution might apply.
To explore this, we undertook a literature search dating back to 1990 using the PsycINFO and MEDLINE databases. We entered the search terms panic disorder, substance abuse, and alcohol. After identifying and gathering articles, we excluded those that had already been addressed in review articles, were written in foreign languages, or reported studies that comprised adolescent participants.
We first examined the lifetime prevalence of alcohol and substance abuse in studies in which participants were identified by a diagnosis of panic disorder. As a prelude to our findings, we encountered a 1990 review article by Brady and Lydiard2 that reported 2 earlier studies in which the prevalence of alcohol abuse or alcoholism was 7% to 8% among panic disorder samples. We located 7 studies published since 1990 (Table 1) that explored the lifetime prevalence of alcohol and substance abuse in participants with panic disorder.3–9 Because the study by Lepine et al.4 did not separate alcohol from substance abuse, we elected to exclude it from the present analysis, bringing the subsequent working sample size to 844 participants. In this subsample, 150 participants (17.7%) with panic disorder were also diagnosed with alcohol abuse or dependence. As for “other substance abuse,” again excluding the Lepine et al. study,4 4 studies comprising 500 participants were relevant. The prevalence of other substance abuse was confirmed in 111 participants (22.2%). In summary, these data indicate that in studies since 1990, approximately 20% of panic disorder patients had lifetime histories of either alcohol or other substance abuse.
Table 1.
Lifetime Prevalence of Alcohol and Substance Abuse Among Study Participants With Panic Disorder
To augment the preceding findings, we examined 2 large community studies that explored the prevalence of alcohol and substance abuse in panic disorder participants during the 12 months preceding assessment. In the first study,10 the prevalence rate of panic disorder among 9282 participants was 2.7%; the correlations between panic disorder and alcohol abuse, alcohol dependence, drug abuse, and drug dependence were 0.27 (significant at p < .05), 0.25, 0.16, and 0.27, respectively. In the second study,11 the prevalence of any comorbid alcohol use disorder during the preceding 12 months in panic disorder participants with and without agoraphobia was 18.8% and 15.3%, respectively, while the prevalence of any comorbid substance abuse disorder was 24.2% and 17.3%, respectively.
We next examined the prevalence of panic disorder in study samples of alcoholics or substance abusers. Brady and Lydiard2 summarized these data up to 1993. Averaging various samples, these authors found that 8.8% (range, 1.0%–20.0%) of participants met the criteria for panic disorder. In the 2 subsequent studies12,13 that emerged during our literature search, the lifetime prevalence rate for panic disorder among alcoholics was 4.1% (144/3475), and among those who abuse or are dependent on sedative/hypnotics, the lifetime prevalence rate was 13.2% (58/441). These rates are substantially less than the rates of alcohol/substance abuse reported in panic disorder samples.
Understandably, it is difficult to accurately assess and compare prevalence rates among studies because of varying assessment tools, different time frames (preceding 12 months vs. lifetime prevalence rates), the timing of the assessment in relationship to detoxification in alcohol and substance abuse populations, patient candor, and varying characteristics of the study population (e.g., primary vs. tertiary care, clinical vs. non-clinical). In addition, we may have missed studies presented at meetings and abstracts, as well as published articles that were not accessed by our search terms. However, these data suggest that approximately 20% of panic disorder patients have lifetime histories of alcohol and/or substance abuse. Because of the substantial rate of comorbidity between panic disorder and alcohol/ substance abuse, clinicians need to screen for these disorders at the outset and exercise caution in prescribing benzodiazepines in this subgroup other than for detoxification.
Footnotes
Drs. R. Sansone, Griffith, and L. Sansone report no financial or other relationship relevant to the subject of this letter.
REFERENCES
- Utilizing Benzodiazepines in Clinical Practice. An Evidence-Based Discussion [Prim Care Companion Editor's Choice Supplement]. J Clin Psychiatry. 2005 66suppl 2. 1–46. [DOI] [PubMed] [Google Scholar]
- Brady KT, Lydiard RB. The association of alcoholism and anxiety. Psychiatr Q. 1993;64:135–149. doi: 10.1007/BF01065866. [DOI] [PubMed] [Google Scholar]
- Himle JA, Hill EM. Alcohol abuse and the anxiety disorders: evidence from the Epidemiologic Catchment Area Survey. J Anxiety Disord. 1991;5:237–245. [Google Scholar]
- Lepine JP, Chignon JM, Teherani M. Suicide attempts in patients with panic disorder. Arch Gen Psychiatry. 1993;50:144–149. doi: 10.1001/archpsyc.1993.01820140070008. [DOI] [PubMed] [Google Scholar]
- Dick CL, Bland RC, Newman SC. Epidemiology of psychiatric disorders in Edmonton. Acta Psychiatr Scand Suppl. 1994;376:45–53. [PubMed] [Google Scholar]
- Katerndahl DA, Realini JP. Relationship between substance abuse and panic attacks. Addict Behav. 1999;24:731–736. doi: 10.1016/s0306-4603(98)00078-1. [DOI] [PubMed] [Google Scholar]
- Mavissakalian M, Guo S. Predictors of entering a long-term drug treatment. Compr Psychiatry. 2002;43:88–94. doi: 10.1053/comp.2002.30803. [DOI] [PubMed] [Google Scholar]
- Marquez M, Segui J, and Canet J. et al. Alcoholism in 274 patients with panic disorder in Spain, one of the main producers of wine worldwide. J Affect Disord. 2003 75:237–245. [DOI] [PubMed] [Google Scholar]
- Sbrana A, Bizzarri JB, and Rucci P. et al. The spectrum of substance use in mood and anxiety disorders. Compr Psychiatry. 2005 46:6–13. [DOI] [PubMed] [Google Scholar]
- Kessler RC, Chiu WT, and Demler O. et al. Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry. 2005 62:617–627. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Grant BF, Stinson FS, and Dawson DA. et al. Prevalence and co-occurrence of substance use disorders and independent mood and anxiety disorders. Arch Gen Psychiatry. 2004 61:807–816. [DOI] [PubMed] [Google Scholar]
- Lydiard R, Brady K, and Ballenger JC. et al. Anxiety and mood disorders in hospitalized alcoholic individuals. Am J Addict. 1992 1:325–331. [Google Scholar]
- Schuckit MA, Smith TL, and Kramer J. et al. The prevalence and clinical course of sedative-hypnotic abuse and dependence in a large cohort. Am J Drug Alcohol Abuse. 2002 28:73–90. [DOI] [PubMed] [Google Scholar]